/RNA

Avidity Biosciences Inc

RNA

$10.36USD↑+0.10%+0.01 today

MARKET CAP

177.2M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$10 – $10

52W RANGE

$10

$73

AI Summary

Stalk

StalkMedium

RNA is in a Stage 2 advancing corrective reset range with short‐term EMAs now acting as support. The medium‐term bias remains bullish anchored by the longer‐term uptrend, but short‐term timing is neutral. We will patient wait for pullbacks into the EMAs around the lower bound of the range to establish a structured entry opportunity rather than executing immediately.

↑FDA cleared ATR 1072 IND on July 29 2026, enabling Phase 1/2 trial.
↑$12 B deal adds three late-stage assets, boosting multi-billion dollar pipeline.
↓Negative earnings yield and low profitability hinder return potential.

Full analysis →

Buying

6

institutions

Selling

10

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	1.45 M	19.47 M	+242.19 K	+20.8%	0.00%
FC Farallon Capital Management LLC Q1 2026	BUYNEW	349.36 K	4.67 M	+349.36 K	+0.0%	0.00%
JH Janus Henderson Group Plc Q1 2026	SELL	279.95 K	3.74 M	+-6.66 M	-99.3%	0.00%
MM Millennium Management LLC Q2 2026	BUY	200.56 K	2.70 M	+9.70 K	+5.7%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUYNEW	172.24 K	2.32 M	+172.24 K	+0.0%	0.00%
PA Polar Asset Management Partners Inc. Q2 2026	BUY	150.00 K	2.02 M	+80.00 K	+115.6%	0.04%
BA Balyasny Asset Management L.P. Q2 2026	SELL	105.88 K	1.42 M	+-129.24 K	-54.7%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	67.64 K	909.75 K	+-42.30 K	-38.1%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	20.83 K	280.22 K	+-10.81 K	-33.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	14.97 K	201.36 K	+14.97 K	+0.0%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	9.39 K	128.15 K	+-43.64 K	-82.2%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	39.00	525.00	+-103.00	-72.3%	0.00%
RC Ra Capital Management, L.P. Q2 2026	SELL	0.00	0.00	+-864.10 K	-100.0%	0.00%
WP Woodline Partners LP Q2 2026	SELL	0.00	0.00	+-57.69 K	-100.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	0.00	0.00	+-22.71 K	-100.0%	0.00%
GM Grantham, Mayo, Van Otterloo & Co. LLC Q2 2026	SELL	0.00	0.00	+-15.44 K	-100.0%	0.00%